Tag Archive: APMA

  1. MIPS Quality Measure #126-Diabetic Foot Neurological Exam

    Leave a Comment


    CMS has recently updated its MIPS (Merit-based Incentive Payment System) Quality Measures. Measure #126 continues to be retained for performance of neurological exams on the feet of diabetic patients. As Measure Steward for this indicator, APMA (American Podiatric Medical Association) has done an excellent job creating a flowchart on implementation. Consistent with prior years, evaluation includes at least annual testing with the 10 gm monofilament plus one of the following:

    Vibration Test Using 128 Hz Tuning Fork
    Pinprick Sensation
    Ankle Reflexes
    Vibration Perception Threshold

    O’Brien Medical is gratified to see that CMS has included vibration testing in two of its four recommended adjunct tests. This decision also reflects current ADA (American Diabetes Association) recommendations.


  2. Dr. O’Brien Lectures on Neuropathy at APMA Region One Conference

    Leave a Comment

    Company CEO, Todd O’Brien, recently presented a lecture at the APMA Region One Conference in Quincy, MA. His topic was an update on diabetic peripheral neuropathy and its clinical implications for medical professionals. The content of the talk was drawn from his own research and experience as well the latest findings from the medical literature.  Approximately 200 podiatrists from the New England region were in attendance.

  3. APMA2015 Meeting a Success

    Leave a Comment

    The company attended it’s first APMA National Meeting in Orlando last week. The event was an excellent venue for showcasing the ETF to the over 1,000 podiatrists in attendance. The company was delighted to have the opportunity to build new relationships with many of the attendees including several nationally recognized thought leaders.


    APMA2015 Booth

    Dr. O’Brien engages in discussion with doctors at the APMA National.